Dec 12 2024 27 mins
Visit https://www.peervoice.com/XMR860 to view the entire programme with slides. After completing “Versha Banerji, MD, FRCPC - Raising the Bar: The Evolving Role of BTK Inhibitors in CLL Management”, participants will be able to: Discuss the evolving role of BTK inhibitors in the management of chronic lymphocytic leukemia (CLL) and how the latest evidence may inform their use; Explain how patient characteristics may impact the choice of CLL therapies and formulate strategies to mitigate/manage safety concerns in patients initiating BTK inhibitors; and Address key questions with respect to CLL care, including remaining unmet needs and potential future solutions.